Outcome
    Limited
    Effectiveness 2/5

    L-Arginine for Nitric Oxide Production

    Oral L-arginine is largely degraded before reaching circulation, so NO effects are small and inconsistent.

    Overview

    Oral L-arginine is largely degraded before reaching circulation, so NO effects are small and inconsistent.

    Verdict

    Not supported

    Poor oral bioavailability makes it the wrong choice - use citrulline.

    How It Works

    Arginine is the direct eNOS substrate, but intestinal and hepatic arginase destroy most of an oral dose.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Not recommended; use citrulline instead
    Expected timeframe
    n/a

    Protocol

    safety
    Do not use with nitrates or after a recent heart attack
    instead
    L-citrulline 6-8 g bypasses first-pass metabolism and raises plasma arginine higher at a lower dose; dietary nitrate from beetroot is the other validated route
    studied dose
    3-9 g/day oral L-arginine
    evidence note
    Verdict is no - oral arginine is a poor way to raise nitric oxide
    what happened
    Effects on flow-mediated dilation and performance were inconsistent, because most oral arginine is destroyed by intestinal and hepatic arginase before it reaches circulation. A post-myocardial-infarction trial was stopped early for safety

    Evidence

    What the studies say

    Trials of oral arginine show inconsistent effects on flow-mediated dilation and exercise performance, and a post-myocardial-infarction trial was stopped early for safety concerns. Citrulline achieves higher plasma arginine at lower doses.

    Oral L-arginine supplementation and endothelial function: a meta-analysis of randomized controlled trials

    Score: 7/10
    2009
    meta_analysis
    n=387

    Bai Y, Sun L, Yang T +3 more

    L-arginine improved flow-mediated dilation, but benefit was confined to impaired baseline endothelial function

    View source

    L-arginine supplementation fails to improve outcomes after acute myocardial infarction: the VINTAGE MI randomized trial

    Score: 8/10
    2006
    rct
    n=153

    Schulman SP, Becker LC, Kass DA +3 more

    L-arginine did not improve vascular stiffness and was associated with more deaths

    View source

    Safety

    Caveats

    Avoid after recent myocardial infarction; may trigger herpes reactivation in susceptible people.

    Less likely to help if

    Almost everyone taking oral arginine for nitric oxide, because of arginase-driven first-pass loss.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.